Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy - Reply

Inmaculada Hernandez; Vinay Prasad; Walid F. Gellad

doi:10.1001/jamaoncol.2018.4657

Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy - Reply

Inmaculada Hernandez, Vinay Prasad, Walid F. Gellad

Knight Cancer Institute

Research output: Contribution to journal › Letter › peer-review

10 Scopus citations

Original language	English (US)
Pages (from-to)	1785-1786
Number of pages	2
Journal	JAMA Oncology
Volume	4
Issue number	12
DOIs	https://doi.org/10.1001/jamaoncol.2018.4657
State	Published - Dec 2018

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1001/jamaoncol.2018.4657

Cite this

@article{98a65c5a867e4c1296d0b228b65454e9,

title = "Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy - Reply",

author = "Inmaculada Hernandez and Vinay Prasad and Gellad, {Walid F.}",

year = "2018",

month = dec,

doi = "10.1001/jamaoncol.2018.4657",

language = "English (US)",

volume = "4",

pages = "1785--1786",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "12",

}

TY - JOUR

T1 - Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy - Reply

AU - Hernandez, Inmaculada

AU - Prasad, Vinay

AU - Gellad, Walid F.

PY - 2018/12

Y1 - 2018/12

UR - http://www.scopus.com/inward/record.url?scp=85054999133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054999133&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2018.4657

DO - 10.1001/jamaoncol.2018.4657

M3 - Letter

C2 - 30325998

AN - SCOPUS:85054999133

SN - 2374-2437

VL - 4

SP - 1785

EP - 1786

JO - JAMA Oncology

JF - JAMA Oncology

IS - 12

ER -

Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy - Reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this